Home > Balance Sheet > CIPLA

CIPLA
Total Non-Current Liabilities

    Back to Balance Sheet
CIPLA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CIPLA
Please provide your vote to see the results

CIPLA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Non-Current Liabilities ₹61 Cr₹-31 Cr₹82 Cr₹184 Cr₹622 Cr

What is the latest Total Non-Current Liabilities ratio of CIPLA ?

The latest Total Non-Current Liabilities ratio of CIPLA is ₹61 Cr based on Mar2026 Consolidated results.
Year Total Non-Current Liabilities
Mar2026₹61 Cr
Mar2025₹-31 Cr
Mar2024₹82 Cr
Mar2023₹184 Cr
Mar2022₹622 Cr

How is Total Non-Current Liabilities of CIPLA Trending?

Years Total Non-Current Liabilities % Change
Mar2026 ₹61 Cr
Positive
Mar2025 ₹-31 Cr
Negative
Mar2024 ₹82 Cr
-55.36
Mar2023 ₹184 Cr
-70.48
Mar2022 ₹622 Cr -

Compare Total Non-Current Liabilities of peers of CIPLA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CIPLA ₹111,894.2 Cr -2.2% -6.1% -12.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹455,634.0 Cr -2.9% -2.3% 21.8% Stock Analytics
DIVIS LABORATORIES ₹241,576.0 Cr -1.6% 9.8% 51.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹184,478.0 Cr -2.6% -2.3% 37.5% Stock Analytics
DR REDDYS LABORATORIES ₹96,322.1 Cr -0.9% -1.8% -9.8% Stock Analytics
MANKIND PHARMA ₹96,179.6 Cr -2.9% -4.2% -6.9% Stock Analytics


CIPLA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CIPLA

-2.2%

-6.1%

-12.5%

SENSEX

-1%

-2.6%

-4.1%


You may also like the below Video Courses